By InvitationNot Applicable

The Efficacy and Adverse Reactions of Neotetracycline in the Treatment of GNB Infections

China300 participantsStarted 2024-03-01

Plain-language summary

A multicenter, retrospective, real-world stduy . Subjects with composite criteria were teated with eravacycline ,and 100 cases ,Tigecycline and 300 cases were to be enrolled.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Bacteriological results show drug-resistant Gram-negative bacteria Use of new tetracycline drugs for ≥72 hours Age ≥18 years Exclusion Criteria: Advanced tumors Severe immunodeficiency or mental illness Severe liver and kidney dysfunction Pregnant or breastfeeding women

What they're measuring

Clinical efficacy

Timeframe: 14 days

Trial details

NCT IDNCT06990126

SponsorThe First Affiliated Hospital with Nanjing Medical University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-07-30

View on ClinicalTrials.gov More Clinical Efficacy and Safety trials